1. Meaning

Biosovereignty Accountability Doctrine Governance is a proposed interdisciplinary legal framework concerning a state's authority and responsibility to govern biological resources, genetic materials, biodiversity, biotechnology, and biological data while protecting the rights of individuals, Indigenous peoples, local communities, and future generations.

The expression is not, by itself, a universally recognized legal doctrine with a single authoritative definition. Instead, it combines three connected ideas:

Biosovereignty: Authority over access to, conservation of, and use of biological and genetic resources.

Accountability: The obligation of governments, regulators, research institutions, biotechnology companies, and other users to explain and justify their decisions and accept legal consequences for violations.

Governance: The laws, institutions, procedures, safeguards, and remedies through which biological resources and technologies are regulated.

The concept draws on established principles of international environmental law, biodiversity legislation, constitutional rights, intellectual property law, bioethics, and Indigenous peoples' rights.

The central question is:

How can a state exercise authority over biological resources without undermining individual rights, community interests, ecological sustainability, scientific freedom, or international legal obligations?

2. Historical and theoretical foundations

Biosovereignty has developed conceptually from several established legal ideas.

A. Permanent sovereignty over natural resources

States exercise authority over their natural resources, subject to international law and applicable treaty obligations. This principle informs national control over biodiversity and genetic resources.

B. Biological diversity and equitable benefit-sharing

Biological resources must be conserved and used sustainably, with fair and equitable sharing of benefits arising from their utilization.

C. Community and Indigenous rights

The governance of genetic resources and associated traditional knowledge may require community participation, appropriate consent, recognition of customary practices, and equitable benefit-sharing.

D. Constitutional accountability

Public authorities must act within legal powers, comply with applicable rights, give legally adequate reasons where required, and remain subject to judicial or other lawful review.

A crucial distinction follows: state sovereignty over biological resources does not necessarily mean absolute state ownership of every organism, human biological sample, genetic sequence, or item of traditional knowledge. Ownership, access rights, regulatory authority, and community entitlements are separate legal questions.

3. Principal legal framework

A. International law

The principal international instruments are:

The Nagoya Protocol entered into force on 12 October 2014. India is a party to it. Its access-and-benefit-sharing framework is especially relevant when biological resources or associated traditional knowledge are used for research and commercial development.

United Nations Treaty Collection+1

Important legal distinction: the Convention on Biological Diversity recognizes state sovereignty over natural resources, but that authority is exercised within the Convention's provisions. It does not give states unrestricted power to disregard domestic constitutional protections, treaty commitments, or applicable community rights.

B. Indian statutory framework

India provides a particularly useful example of biosovereignty accountability governance.

Key legislation and institutions

Biological Diversity Act, 2002

Establishes the statutory framework for biodiversity conservation, sustainable use, and fair and equitable sharing of benefits.

National Biodiversity Authority (NBA)

Performs statutory functions concerning access to biological resources, associated traditional knowledge, benefit-sharing, and specified intellectual-property activities.

State Biodiversity Boards and Biodiversity Management Committees

Support state-level regulation and local participation, documentation, and conservation, subject to their respective statutory powers.

Courts and the National Green Tribunal

Provide judicial or statutory review and remedies within their respective jurisdictions.

The Act must be read in its current amended form, alongside the applicable rules and regulations. The Biological Diversity (Amendment) Act, 2023, and the Biological Diversity Rules, 2024, are particularly relevant to present-day compliance. India's official implementation materials describe a framework involving consultation with Biodiversity Management Committees and local-community participation in access decisions.

Access and Benefit-Sharing Clearing-House+1

4. Core principles of the doctrine

4.1 Sovereign authority with legal limits

A state may regulate access to biological resources, impose lawful conservation conditions, and establish benefit-sharing mechanisms. However, the exercise of authority must have a legal basis and comply with constitutional and international obligations.

For example, a government cannot treat its regulatory authority over medicinal plants as an unlimited right to appropriate every community's traditional knowledge without regard to applicable law.

4.2 Prior informed consent and community participation

The legal question is not simply whether the state has granted permission. It is also whether the applicable law requires the approval, prior informed consent, or involvement of Indigenous peoples or local communities.

A sound governance system should establish:

Who has authority to grant access or approval.

Whether community consent or involvement is legally required.

What information must be disclosed before consent is obtained.

How traditional knowledge is protected.

How disagreements over representation and customary rights are resolved.

The exact requirements vary with the resource, the jurisdiction, the parties, and the relevant statutory or treaty provisions.

4.3 Fair and equitable benefit-sharing

Where the applicable access-and-benefit-sharing regime applies, benefits arising from biological resources or associated knowledge must be shared according to the governing law and relevant agreements.

Benefits may include:

Monetary payments and royalties.

Research partnerships and technology transfer.

Training and scientific capacity-building.

Community development and conservation funding.

Appropriate recognition of knowledge holders.

Benefit-sharing is not merely a commercial issue. It is also an accountability mechanism intended to reduce inequitable appropriation and create incentives for biodiversity conservation.

4.4 Transparency and traceability

Authorities and users should maintain reliable records of the origin of biological materials, permissions, transfers, research uses, commercial development, and benefit-sharing obligations.

Where required by law, such records should support regulatory inspection, disclosure, and verification. Confidential information and legitimate privacy interests must also be protected.

4.5 Ecological responsibility

Sovereignty does not eliminate the state's responsibility to protect biodiversity. Decisions concerning species relocation, genetic-resource extraction, biotechnology, or habitat modification should take account of scientific evidence, ecological risks, and affected communities.

4.6 Access to remedies

A meaningful accountability system must allow affected parties to challenge unlawful decisions, seek review, and obtain appropriate relief. Depending on the applicable law, remedies may include cancellation of an authorization, reconsideration of a decision, payment of benefits, restoration, compensation, or penalties.

5. Landmark case laws and their relevance

The following cases do not all use the label biosovereignty. They are judicial authorities relevant to the legal principles from which a biosovereignty accountability framework can be developed.

Case 1. Divya Pharmacy v. Union of India

Uttarakhand High Court · 2018 · Writ Petition (M/S) No. 3437 of 2016

Facts: Divya Pharmacy, an Indian company manufacturing Ayurvedic medicines and nutraceutical products, challenged a demand for fair and equitable benefit-sharing raised by the Uttarakhand Biodiversity Board. The dispute included whether such obligations could apply to an Indian company without foreign participation.

Legal issue: Could benefit-sharing obligations under India's biodiversity framework extend to an Indian company commercially using biological resources?

Decision and significance: The High Court rejected the narrow interpretation that would confine the benefit-sharing obligation to foreign entities. It interpreted the statutory framework in light of the Act's objectives and India's international commitments. The judgment is widely regarded as an important Indian decision on benefit-sharing and the interests of local communities.

National Cases+1

Relevance to the doctrine: This case illustrates that biosovereignty is not only about the state's power to control resources. It also concerns the distribution of benefits and the accountability of domestic commercial users.

Case 2. Dabur India Limited v. National Biodiversity Authority

National Green Tribunal, Southern Zone · 20 December 2023 · Appeal No. 54 of 2022 (SZ)

Facts: Dabur challenged aspects of the application of India's access-and-benefit-sharing guidelines to its commercial use of biological resources in manufacturing Ayurvedic and healthcare products.

Legal issue: How should benefit-sharing obligations be calculated and applied to a company that uses biological resources purchased through supply chains?

Importance: The Tribunal examined the statutory purpose of access and benefit-sharing, the applicable regulatory provisions, and the method of determining the company's obligations. It emphasized the role of benefit-sharing in supporting innovation while creating incentives for conservation and equitable distribution.

Indian Kanoon+1

Relevance to the doctrine: The case demonstrates why accountable biosovereignty requires clear formulas, consistent administrative decisions, and reviewable financial obligations—not merely broad assertions of state control.

Practical lesson: Businesses should assess applicable access-and-benefit-sharing requirements early in their supply chains and maintain records of biological-resource sourcing, commercial utilization, and regulatory compliance.

Case 3. Centre for Environment Law, WWF-India v. Union of India

Supreme Court of India · 2013 · Asiatic lion translocation proceedings

Facts: The dispute concerned the long-term survival of Asiatic lions, then concentrated in Gujarat's Gir landscape, and the proposal to establish a second free-ranging population at Kuno in Madhya Pradesh.

Legal issue: How should the state discharge its conservation responsibilities when a threatened species' survival may depend on establishing an additional habitat?

Judicial significance: The Supreme Court addressed the need for long-term species conservation and considered ecological evidence, habitat suitability, and the responsibilities of public authorities. The judgment is an important authority on wildlife conservation and the public duties associated with biodiversity protection.

Sci API+1

Relevance to the doctrine: Biological sovereignty entails stewardship rather than merely ownership or territorial control. A state must consider scientific evidence and long-term ecological survival when making decisions about endangered species.

Case 4. Gene Campaign v. Union of India

Supreme Court of India · 2024 · 2024 INSC 545

Facts: The proceedings raised questions about genetically modified organisms and crops, environmental and health risks, regulatory safeguards, and the application of India's environmental and biotechnology framework.

Legal significance: The litigation addressed the regulatory and constitutional dimensions of biotechnology, including environmental protection, biosafety assessment, and the role of public authorities in decisions affecting agriculture and biological systems. The judgment should be read for its specific holdings rather than treated as a general prohibition on genetically modified organisms.

VoxJuris

Relevance to the doctrine: Biosovereignty accountability must include scientific scrutiny, lawful risk assessment, reasoned regulatory decisions, and public participation where required. A state's control over biotechnology does not dispense with the need to justify regulatory choices.

Case 5. W.R. Grace and Co. — Neem patent dispute

European Patent Office · Opposition proceedings concerning European Patent No. 0436257

Facts: A patent concerning the fungicidal properties of neem oil was challenged on the basis that the claimed invention was already known through traditional practices and prior use in India.

Legal significance: The European Patent Office revoked the patent in 2000 after opposition proceedings, with the decision subsequently upheld on appeal. The dispute is a prominent example of the difficulty of protecting traditional knowledge against patent claims based on pre-existing practices.

Relevance to biosovereignty: A country or community's biological knowledge can be commercially valuable even when it is not formally recorded in conventional scientific literature. Traditional-knowledge documentation, patent examination, and mechanisms for challenging invalid patents can help prevent unjustified monopolization.

This is an intellectual-property dispute, not a judicial declaration that all uses of neem or all patents involving natural resources are unlawful. The broader problem of appropriation without benefit-sharing is discussed in legal scholarship on genetic resources and the Nagoya Protocol.

Chicago Journal of International Law+1

Case 6. The Quassia amara biopiracy controversy

French Guiana · Research and patent controversy, 2015 onward

Facts: Researchers associated with France's Institut de Recherche pour le Développement faced public allegations of biopiracy following work involving simalikalactone E, a bioactive molecule isolated from Quassia amara. The controversy involved the relationship between scientific research, local medicinal knowledge, patent applications, and the emerging implementation of the Nagoya Protocol.

Legal significance: This controversy illustrates the importance of determining whether the relevant access, consent, and benefit-sharing requirements have been met. The allegations themselves should not be treated as proof of a final judicial finding of unlawful conduct.

Relevance to biosovereignty: Scientific research should have a clear legal and ethical basis, including an assessment of applicable access rules and the rights of communities whose knowledge may have contributed to the discovery.

ScienceDirect+1

6. How accountability governance should operate

A practical biosovereignty system needs an enforceable decision-making process rather than simply a declaration of national authority.

1. Identify the biological resource

Species, genetic material, biological sample, or associated knowledge

2. Determine legal authority and rights

Jurisdiction, ownership, community interests, and applicable access rules

3. Assess risks and participation requirements

Scientific evaluation, consultation, consent where required, and safeguards

4. Authorize and monitor use

Permits, agreements, traceability, disclosure, and benefit-sharing

5. Audit, review, and remedy

Independent oversight, appeals, sanctions, compensation, or corrective action where legally justified

Institutional responsibilities

7. Constitutional dimensions in India

Biosovereignty accountability can be connected to several provisions of the Constitution of India. These provisions do not collectively create a separately named constitutional doctrine of biosovereignty; rather, they supply constitutional principles relevant to its development.

Article 14 — Equality before the law: Public authorities must comply with applicable equality and non-arbitrariness requirements when regulating biological resources.

Article 21 — Protection of life and personal liberty: Environmental protection, health, privacy, and bodily autonomy may be implicated by particular biological policies, depending on the facts and applicable precedents.

Article 48A — Environmental protection: Directs the State to protect and improve the environment and safeguard forests and wildlife.

Article 51A(g) — Fundamental duty: Calls upon citizens to protect and improve the natural environment and have compassion for living creatures.

Article 300A — Property: May be relevant where a dispute concerns deprivation of legally protected property, subject to the nature of the property and the applicable law.

These provisions must be applied according to their legal character, scope, and the relevant judicial authorities. For instance, Article 48A is a Directive Principle, whereas Article 21 is a fundamental right.

8. Legal challenges and limitations

A biosovereignty accountability framework faces several difficult questions.

First, sovereignty versus community rights. National governments may control access under domestic legislation, but this does not automatically settle who should receive benefits or how traditional knowledge should be protected.

Second, sovereignty versus scientific openness. Excessively restrictive rules may obstruct legitimate research, conservation partnerships, and the development of useful medicines. Regulation should distinguish unlawful appropriation from lawful research.

Third, biological samples versus digital sequence information. A physical sample and digital genetic sequence derived from it may raise different legal issues. Whether a particular access-and-benefit-sharing obligation applies depends on the governing legal instrument and domestic implementation.

Fourth, enforcement across borders. Genetic material, data, patents, and commercial products may pass through several jurisdictions. Effective accountability therefore requires cooperation between national regulators, patent offices, research institutions, and international mechanisms.

Fifth, regulatory capture and corruption. An authority responsible for controlling biological resources may face pressure from commercial or political interests. Disclosure, reasoned decisions, independent review, conflict-of-interest safeguards, and auditable benefit-sharing arrangements can reduce these risks.

Sixth, changing legislation. India's biodiversity legislation has been amended, and the applicable rules can vary according to the date and nature of the activity. A legal opinion must therefore distinguish the law applicable when access occurred from the law currently in force.

9. A proposed legal test for biosovereignty accountability

For academic or policy analysis, the following six-part test can be used to assess a contested decision involving biological resources.

Authority: Did the decision-maker have lawful jurisdiction and statutory authority?

Rights: Were applicable individual, property, Indigenous, community, and traditional-knowledge rights respected?

Evidence: Was the decision supported by appropriate scientific, environmental, and factual evidence?

Procedure: Were applicable notice, consultation, consent, disclosure, and hearing requirements satisfied?

Equity: Were access conditions and benefit-sharing arrangements lawful, fair, and consistent with the governing framework?

Review and remedy: Is the decision open to appropriate scrutiny, and are effective remedies available for violations?

This is a proposed analytical framework, not a six-part test formally adopted by the Supreme Court of India or an international treaty.

10. Conclusion

The Biosovereignty Accountability Doctrine Governance concept brings together national authority over biological resources, ecological stewardship, community rights, equitable benefit-sharing, and public accountability.

The Indian cases of Divya Pharmacy, Dabur India, Centre for Environment Law, WWF-India, and Gene Campaign illustrate different parts of this legal landscape: benefit-sharing, regulatory compliance, wildlife conservation, and biotechnology oversight. The neem patent dispute and the Quassia amara controversy further demonstrate the importance of traditional knowledge and cross-border research governance.

The fundamental proposition is that biological sovereignty should not be understood as unlimited state control. It should be exercised through lawful institutions, evidence-based decisions, meaningful participation, appropriate benefit-sharing, and effective remedies.

Academic qualification: The phrase itself is best treated as a proposed doctrinal synthesis, not as an established, independently binding rule of law. Its legal force in any particular dispute must come from applicable constitutional provisions, statutes, regulations, treaties, contracts, and judicial decisions.